Mutations in the tumor suppressor protein PTEN (phosphatase and tensin homologue deleted on chromosome 10) enhance cell migration, yet the underlying molecular mechanisms remain largely uncharacterized. Loss of PTEN in mouse embryonic fibroblasts (MEFs) correlates with striking cortical actin accumulation. However, how loss of PTEN leads to cortical actin formation and whether the presence of cortical actin contributes to the increased cell migration are unclear. Here we show that overexpression of dominant-negative forms of (DN) PTEN, RhoA or its kinase-dead (KD) effector, PKN, inhibited cortical actin formation, indicating that cortical actin of Pten À/À MEFs is mediated by the PTEN/Rho/PKN pathway. However, neither DN RhoA nor KD PKN inhibited the enhanced migration of Pten À/À cells, in contrast to the inhibitory effect of DN Rac. In agreement with the previous observation that DN Akt inhibits migration of Pten À/À cells, we demonstrate here that overexpression of KD PDK-1, the Akt kinase, reduces Pten À/À cell migration. Furthermore, overexpression of DN forms of Akt, Rac, or PDK-1, all of which inhibit migration of Pten À/À cells, had no effect on cortical actin accumulation. Our findings suggest that PDK-1/Akt signaling pathway plays a major role in regulating cell migration induced by PTEN deficiency.
Introduction
PtdIns(3,4)P 2 and PtdIns(3,4,5)P 3 levels in cells are regulated by PTEN, a phosphatase that dephosphorylates both these phosphoinositides at the 3-position (Maehama and Dixon, 1998; Dahia, 2000) . The PTEN gene was originally identified as a tumor suppressor gene located at 10q23.3. This gene is deleted in a wide variety of human cancers such as prostate, breast and endometrial cancers, as well as in glioblastomas and melanomas (Furnari et al., 1997; Li et al., 1997; Risinger et al., 1997; Steck et al., 1997; Cairns et al., 1998) . PTEN acts opposite to PI 3-kinase by inducing growth suppression via cell cycle arrest and/or induction of apoptosis, and by inhibiting cell adhesion and migration (Dahia, 2000) .
Pten mutations have been found in far advanced metastatic cancers, particularly in high-grade gliomas (44%) and certain types of endometrial cancers (55%) (Mertens et al., 1997; Wang et al., 1997; Hahn et al., 1999) . Introduction of PTEN into PC-3 prostate cancer and B16F10 melanoma cells has been shown to suppress the metastasis of these tumors in vivo by a yet uncharacterized mechanism (Celebi et al., 2000; Hwang et al., 2001; Davies et al., 2002) .
The PI 3-kinase pathway is a major pathway involved in regulating cellular actin remodeling in response to growth factor stimulation (Rijken et al., 1991; Wennstrom et al., 1994; Nobes et al., 1995; Ojaniemi and Vuori, 1997; Tsakiridis et al., 1999; Dong et al., 2000) . An array of different proteins bind to the lipid products of PI 3-kinase and are recruited to the plasma membrane. These proteins typically contain a pleckstrin homology (PH) domain that mediates binding to PtdIns(3,4)P 2 and PtdIns(3,4,5)P 3 (Lemmon and Ferguson, 2000) . Examples of PH-domain-bearing proteins include guanine nucleotide exchange factors (GEFs) for small G proteins (Musacchio et al., 1993; Franke et al., 1997; Stephens et al., 1998; Balendran et al., 1999; Rameh and Cantley, 1999; Lemmon and Ferguson, 2000; Vanhaesebroeck et al., 2001) , Akt (protein kinase B) and 3 0 -phosphoinositide-dependent kinase-1 (PDK-1).
The actin cytoskeleton is predominantly regulated by members of the Rho family GTPases (Burridge and Wennerberg, 2004) . Rho GTPases (Rho, Rac and Cdc42) are activated by GEFs which promote the exchange of GDP for GTP upon binding to PtdIns(3,4,5)P 3 (Han et al., 1998; Scita et al., 2000) .
Activation of Rho results in formation of stress fibers and focal adhesion, whereas activation of Rac and Cdc42 results in lamellipodia and filopodia formation, respectively (Burridge and Wennerberg, 2004) . Rho activates many proteins including Rho-kinases (ROCKs), mDia and protein kinase N (PKN) (Burridge and Wennerberg, 2004) . Stress fiber formation is promoted when ROCK phosphorylates and activates LIM-kinase (LIMK), which subsequently phosphorylates and inactivates cofilin, an actin-depolymerizing factor, resulting in net polymerization of actin filaments (Riento and Ridley, 2003) .
We recently discovered another PI 3-kinase-dependent pathway that regulates the actin cytoskeleton . In this pathway, insulin-induced loss of actin stress fibers and accumulation of cortical actin are mediated by PDK-1 phosphorylation and activation of PKN. This actin phenotype, which can be induced by overexpression of either PDK-1 or PKN in 3T3-L1 and Rat1 cells, appears to be similar to the actin phenotype of Pten À/À MEFs. PDK-1 is a cytoplasmic Ser/Thr kinase that translocates to the plasma membrane upon binding of PtdIns(3,4)P 2 and PtdIns(3,4,5)P 3 , where it phosphorylates Akt . PKN acts further downstream of PI 3-kinase and is activated by either RhoA binding or phosphorylation by PDK-1 (Amano et al., 1996; Watanabe et al., 1996; Dong et al., 2000) .
The cell migration process -lamellipodia formation, cell body contraction and detachment of adhesion at the rear of the cell -is driven by changes in the actin network (Raftopoulou and Hall, 2004) . MEFs and prostate cancer cells deficient in PTEN exhibit loss of actin stress fibers (Liliental et al., 2000) characteristic of malignant transformation of fibroblasts by oncogenic proteins such as Ras (Bar-Sagi and Feramisco, 1986; Barbacid, 1987; Maruta et al., 1999) , and accumulation of cortical actin. The signaling pathway responsible for mediating loss of actin stress fibers and cortical actin accumulation in PTEN-deficient cells is unknown, whereas the increased migration of these cells has been attributed to increased Rac and Akt activities (Liliental et al., 2000; Higuchi et al., 2001) . In this study, we investigated the potential link between actin rearrangement and increased motility of the Pten À/À MEFs. We found that the Rho pathway but not the PDK-1 pathway is involved in mediating the cortical actin formation of Pten À/À MEFs. In contrast, cell migration is regulated by the PDK-1/Akt pathway but not the Rho pathway. Our results indicate that PDK-1 plays a novel and potentially important role in promoting cell migration downstream of PTEN.
Results

Characterization of Pten
À/À cell line
In order to identify the signaling molecules involved in mediating actin reorganization and cell migration in Pten À/À cells, we examined the expression profiles of components of the PI 3-kinase pathway. Western blot analysis indicated that both Pten þ / þ and Pten À/À cell lines expressed downstream effectors of PI 3-kinase, such as PDK-1, Akt, PKN and PKC-related kinase 2 (PRK2) (data not shown). In agreement with our previous findings (Liliental et al., 2000) , the actin cytoskeleton of the Pten À/À cells is strikingly different compared to the Pten þ / þ cells (Figure 1a , panels II and I, respectively). Treatment of cells with the PI 3-kinase pharmacological inhibitor, LY294002 (Figure 1a , panel IV), in the presence of serum led to approximately a 20-30% reduction in the number of cells exhibiting cortical F-actin compared to cells treated with vehicle ( Figure 1a (Figure 1b and c), whereas overexpression of either the C124S or the G129E mutant had no effect. These results support the hypothesis that cortical actin is caused by loss of PTEN, and that loss of the lipid phosphatase activity of PTEN is responsible for this actin phenotype.
The Rho pathway is involved in regulating cortical actin formation in Pten À/À MEFs
In a previous study, we showed that the Ser/Thr kinases PDK-1 and PKN are involved in regulating the insulininduced loss of actin stress fibers and accumulation of cortical actin in 3T3-L1 and Rat1 cells . Here we examined whether PDK-1 and PKN produced similar effects in Pten þ / þ cells. PDK-1 overexpression led to an approximately 10-15% increase in the number of cells exhibiting actin reorganization, which is predominantly loss of actin stress fibers, whereas approximately 50% of Pten þ / þ cells overexpressing PKN exhibited loss of stress fibers and/or increased cortical F-actin formation (Figure 2 ). Overexpression of PRK2, a PKN isoform, had only a slight effect on actin structure in a small proportion of cells (Figure 2 (Figure 3a) . In contrast, overexpression of FLAG-PKN K644D resulted in significant inhibition of cortical actin formation (Figure 3a and b) . However, stress fibers were not restored in cells expressing FLAG-PKN K644D . These findings suggest that PKN plays a role in cortical actin but not stress fiber formation of Pten À/À cells. PKN is a 120 kDa protein composed of a regulatory N-terminus with leucine-zipper-like motifs and a Cterminal kinase domain that resembles the kinase domain of the protein kinase C family Palmer et al., 1995) . The PKN N-terminus interacts with numerous proteins, most of which are involved in modulating cytoskeletal stability and dynamics. RhoA is the best-characterized activator of PKN; binding of activated Rho to the PKN N-terminus activates PKN both in vitro and in vivo Amano et al., 1997; Lu and Settleman, 1999) . We examined the roles of members of the Rho GTPase family in regulating cortical actin formation by overexpressing dominant-negative (DN) RhoA (Rho Wennerberg, 2004) . We therefore investigated whether PTEN deficiency leads to activation of the Rho pathway by first examining whether Rho activation is increased in Pten À/À cells. As only activated Rho (Rho-GTP) binds to rhotekin (Reid et al., 1996) , we performed pulldown assays using rhotekin fused to GST to affinity precipitate endogenous activated Rho from Pten À/À cells and wild-type cells. As shown in Figure 6a and b, a (Figure 6c and d) , indicating that PKN activation in these cells is dependent on heightened PtdIns(3,4,5)P 3 levels. The observation that endogenous Rho and PKN have increased activities in Pten À/À cells supports the hypothesis that the Rho/PKN pathway is activated and plays a role in regulating cortical actin formation in these knockout cells.
Cortical actin does not play a role in promoting cell migration
Previous studies using pharmacological inhibitors of PI 3-kinase indicated that the PI 3-kinase pathway plays a role in regulating cell motility of cancer cell lines. For example, wortmannin has been shown to inhibit hepatocyte growth factor-stimulated migration of primary hepatocellular carcinoma (HCC) cells from different patients (Nakanishi et al., 1999) . Treatment of the highly invasive PC-3 prostate cancer and MDA-MB-231 breast cancer cell lines with wortmannin and/or LY294002 attenuated basal cell migration Sliva et al., 2002) . Consistent with these findings, Pten À/À MEFs was shown to possess increased motility compared to Pten þ / þ cells (Liliental et al., 2000) . Rac1, Cdc42 (Liliental et al., 2000) and their downstream effector, Akt (Higuchi et al., 2001) inhibited Pten À/À cell migration compared to those infected with adenovirus encoding GFP alone (Figure 7a, right panel) . Taken together, the data suggest that disruption of cortical actin has no effect on migration of Pten À/À cells, and that these two are separate events. This hypothesis is further supported by the observation that DN Rac (Rac The observation that kinase-dead PDK-1 inhibits migration of Pten À/À cells suggests that this kinase may be activated in these cells. Regulation of PDK-1 function could occur via two distinct mechanisms that may not be mutually exclusive: increase in intrinsic PDK-1 kinase activity or increase in translocation of PDK-1 to the plasma membrane. We first investigated whether PDK-1 is activated in Pten (Figure 7b and c) . However, PDK-1 is a predominantly cytoplasmic protein which translocates to the plasma membrane upon binding the lipid products of PI 3-kinase (Vanhaesebroeck and Alessi, 2000) . We therefore examined whether the basal localization of Myc-tagged PDK-1 was increased in Figure 7d , wild-type PDK-1 is only found at the membrane of 6% of the Pten þ / þ cell population under basal conditions, whereas approximately 34% of the Pten À/À cells population showed PDK-1 membrane Actin organization and migration of Pten À/À cells MA Lim et al localization, which represents an approx. 6-7-fold in plasma membrane localization. Studies performed with PDK-1 K114G yielded similar results. The increased membrane localization of PDK-1 may explain why Akt phosphorylation is increased in PTEN-deficient MEFs ( (Stambolic et al., 1998) and our unpublished observations). The increased PDK-1/Akt signaling in Pten À/À cells may contribute to the increased motility of these cells.
cells. As shown in
Discussion
In this study, we demonstrated that the RhoA pathway is involved in regulating cortical actin accumulation in Pten cells is that PKN is regulating a subset of Rho-induced responses, which is unrelated to stress fiber formation. As the major pathway responsible for stress fiber formation in cells is the Rho/Rho-kinase (ROCK) pathway (Riento and Ridley, 2003) , the observation that DN Rho and KD LIMK1 (downstream ROCK effector) could not restore actin stress fibers of Pten À/À cells indicates that the loss of stress fibers is regulated by a more complex mechanism.
Our results show that kinase-dead PDK-1 inhibits migration of Pten À/À cells to the same extent as Rac N17 (Figure 7a ). These findings are in agreement with the observation that DN Akt can inhibit cell migration of Pten À/À MEFs (Higuchi et al., 2001) , and suggest that PDK-1 may act upstream of Akt in promoting cell motility of these fibroblasts. However, overexpression of PDK-1 K114G has no effect on cortical actin, whereas overexpression of kinase-dead PKN inhibited this actin phenotype. As PDK-1 has been reported to activate both Akt and PKN (Alessi et al., 1997; Dong et al., 2000) , these observations suggest that the PI 3-kinase/ PTEN pathway bifurcates into two distinct pathways in the Pten À/À cells, the PDK-1/Akt pathway regulates cell motility, whereas the Rho/PKN pathway regulates cortical actin accumulation. In order to investigate this hypothesis, we investigated the effect of adenoviralmediated PDK-1 K114G overexpression on endogenous Akt and PKN activities. PDK-1 K114G overexpression in Pten À/À cells inhibited Akt activity, but had no effect on PKN activity (Figure 7e, top vs bottom panels) . This The mechanism by which PDK-1 K114G inhibits cell motility induced by PTEN deficiency is unclear. As PDK-1 K114G localization is also increased at plasma membrane of Pten À/À cells (data not shown), it is possible that PDK-1 K114G acts by sequestering endogenous Akt at the plasma membrane. Thus, it is possible that increased Akt phosphorylation observed in this cell line is due to increased PDK-1 membrane/cortical localization and that PDK-1 may promote increased DPH inhibited the migration of Pten À/À MEFs to the same extent as PDK-1 K114G (data not shown). However, this observation is consistent with a previous publication showing that overexpression of a translocation-deficient PDK-1 mutant prevented Akt from moving to the cell periphery upon insulin stimulation (Filippa et al., 2000) . Thus, PDK-1 DPH may function as a DN by inhibiting Akt membrane translocation.
Interestingly, we found that overexpression of constitutively active PDK-1 (A280V) alone is not sufficient to promote cell migration in Pten þ / þ cells (data not shown). This finding suggests that PDK-1 may be acting in concert with other signaling proteins downstream of PI 3-kinase to regulate cell migration. The mechanism by which PDK-1 affects cell migration definitely warrants further investigation.
In conclusion, our results suggest that cortical actin polymerization and cell migration in PTEN-deficient cells are regulated by different mechanisms. The former is regulated by the Rho pathway, whereas the latter appears to be regulated by PDK-1 and Akt. Taken together, our results suggest that these two signaling pathways may bifurcate downstream of PI 3-kinase to regulate cortical actin formation and cell migration.
The involvement of PI 3-kinase, PTEN and Akt in many aspects of oncogenesis has been extensively studied (Vara et al., 2004) , whereas the role of PDK-1 in promoting oncogenesis has been mostly neglected. Recently, Zeng et al. (2002) showed that forced expression of PDK-1 induced anchorage-independent growth in vitro, and isografts of PDK-1 transforming cell lines into syngeneic mice induced the formation of poorly differentiated mammary carcinomas. Here, we demonstrate that PDK-1 may be involved in promoting cell migration downstream of PTEN inactivation. These results suggest that PDK-1 can promote both tumor formation and progression, and imply that PDK-1 may be an attractive target for the development of anti-cancer drugs.
Materials and methods
Cell lines, cDNAs and antibodies
Isogenic Pten þ / þ and Pten À/À MEF cell lines and retroviral vectors encoding PTEN WT, C124S and G129E were described previously (Liliental et al., 2000) . cDNAs encoding FLAG-PKN truncations/mutants (Takahashi et al., 1998; Dong et al., 2000) and PDK-1 mutants were described previously (Dong et al., 1999; Wick et al., 2000) . The cDNA encoding FLAG-LIMK1 D460E was a kind donation from Dr Ora Bernard (Bernard et al., 1994) . Monoclonal anti-FLAG, anti-Myc and anti-HA antibodies were purchased from Sigma, Santa Cruz Biotechnologies and BABCO, respectively. The anti-PKN monoclonal and anti-PTEN polyclonal antibodies were purchased from Transduction Laboratories and Cell Signaling Technology, respectively. The anti-goat PDK-1 antibody was generated by immunizing goats (Ferrell Farms, Inc., OK) with purified recombinant mouse PDK-1 carboxyl terminus (amino-acid residues 285-559) fused to glutathione-S-transferase (GST).
Generation of FLAG-tagged PKN N-terminus (PKN-N)
cDNA encoding the N-terminus of human PKN was generated by PCR by using the PCR primers: 5 0 -cccggatatccagcgacgccgtgcaga-3 0 and 5 0 -cgcacccacgtgtcgacatcgatgttc-3 0 (added restriction sites underlined). Following EcoRV and SalI restriction digest, the insert was ligated into pFLAG-CMVt-2 (Sigma), in-frame with a sequence encoding the FLAG tag at the N-terminus.
In vitro kinase assays
Subconfluent cells growing in 100 mm plates were preincubated with either vehicle (DMSO) or 50 mM LY294002 for 1 h in growth medium at 371C in experiments using PI 3-kinase inhibitors. Pten þ / þ and/or Pten À/À cells were lysed in either Buffer A for PDK-1, or modified Buffer A for PKN immunoprecipitations. Lysates were incubated with either goat anti-PDK-1 or mouse anti-PKN antibody pre-absorbed onto protein-G-sepharose at 41C for 6 h with mixing. Bound proteins were washed three times with ice-cold Buffer B (50 mM HEPES, pH 7.6, 150 mM NaCl, 0.1% Triton X-100 for PDK-1 or NP-40 for PKN) and twice with Buffer C (50 mM Tris, pH 7.5, 5 mM MgCl 2 , 1 mM NaF, 0.1 mM Na 4 O 7 P 2 , 0.1 mM Na 3 VO 4 , 1 mg/ml leupeptin, 1 mg/ml aprotinin and 1 mM PMSF). PKN in vitro kinase assay was carried out in a 25 ml of Buffer C containing 1 mCi of [g-32 P]ATP and 0.4 mg/ml MBP (Sigma) at 301C for 30 min. To determine PKN activity, one-third of the reaction volume containing MBP was removed from the beads and loaded onto 15% SDS gel. The gels were stained with Coomassie blue and phosphorylation levels were quantified by phosphoimager analysis (ImageQuant 5.0). The protein level of PKN was quantified by eluting bound proteins, SDS-PAGE, and Western blotting with an anti-PKN antibody. The kinase activity was calculated by dividing the MBP phosphoimager values (total counts) by PKN protein levels (NIH Image 1.58) and the relative PKN activity was obtained by comparing the values obtained for Pten À/À cells against that from Pten þ / þ cells (100%). PDK-1 in vitro kinase assay was carried out for 15 min at 301C in Buffer C containing 1 mCi of [g-32 P]ATP in the presence of kinase-dead PKN C-terminus (PKN-C KD , amino acids 561-942) immobilized on anti-FLAG/protein-G-sepharose beads. PDK-1 kinase activity was determined by separating the radiolabeled proteins by SDS-PAGE and Western blotting. The nitrocellulose membrane was exposed on the phosphoimager prior to Western blotting with either rabbit anti-PDK-1 or mouse anti-FLAG antibodies. PDK-1 kinase activity was obtained by dividing PKN-C KD phosphorylation values (total counts) by PDK-1 loading levels. Endogenous PDK-1 kinase activity from Pten þ / þ cells was arbitrarily assigned as 100% and the PDK-1 kinase activity from Pten À/À cells was expressed relative to this value. At approximately 24 h post-infection, the cells were directly lysed in SDS buffer and the protein separated on SDS gel. Western blot was performed to determine phosphorylation of Akt at Thr308, the PDK-1 phosphorylation site required for Akt activation (Alessi et al., 1997) . Akt phosphorylation and loading levels were quantified using Scion Image, and Akt phosphorylation was normalized against protein-loading levels. Akt phosphorylation of GFP-infected cells was arbitrarily assigned as 100% and Akt phosphorylation from PDK-1 K114G -infected cells was expressed relative to this value.
Endogenous RhoA activity assay
The GST-Rhotekin probe containing the RhoA-binding domain was expressed and purified from Escherichia coli as described previously (Li et al., 1999) . Cells were washed once with ice-cold phosphate-buffered saline (PBS) buffer prior to lysis in Buffer D (50 mM Tris-HCl (pH 7.4), 100 mM NaCl, 10 mM MgCl 2 , 1% Triton X-100, 0.1% SDS, 10 mg/ml each of leupeptin and aprotinin, and 1 mM PMSF). Following centrifugation at 13 000 g at 41C for 10 min, equal amounts of cell lysates were incubated with the GST-Rhotekin probe (10 mg/sample) immediately for an hour at 41C under constant agitation. The precipitated beads were washed three times with the lysis buffer, and the bound RhoA was detected by antiRhoA (Santa Cruz Biotechnology) Western blotting. Quantification of the Western blots was carried out using an AlphaImager system (Alpha Innotech). To compare the level of the active RhoA-GTP in GST-Rhotekin pulldowns, the amount of co-precipitated RhoA was normalized to the total amount of RhoA in different samples.
Cell staining and actin studies
At 18-24 h post-transfection, Pten þ / þ and/or Pten À/À cells growing on glass coverslips were fixed with 4% paraformaldehyde/PBS for 20 min, followed by permeabilization with 0.2% Triton X-100/PBS for 3 min at room temperature. Cells were stained with monoclonal anti-FLAG, anti-Myc or anti-HA antibody, followed by incubation with either anti-mouse Alexa Fluor 488 or 350 (Molecular Probes), and counterstained for polymerized/filamentous actin (F-actin) using rhodamine phalloidin (Molecular Probes). Coverslips were mounted on glass slides using the ProLong Antifade Mounting reagent (Molecular Probes).
Cell migration assays
Pten
þ / þ or Pten À/À cells growing in 100 mm plates were transfected with cDNAs encoding Rho N19 , Rac
N17
, PKN K664D , PDK-1 K114G or PDK-1 DPH with pEGFP-C1 to a 10 to 1 ratio, respectively, using Lipofectamine (GibcoBRL). After 24 h, the cells were detached by EDTA treatment and approximately 10 000-20 000 GFP-positive cells were added to the top chamber of a 24-well Transwell unit (8 mm pore size, Corning). Fibronectin (10 mg/ml) diluted in DMEM/0.1% BSA was added to the bottom chamber. A fraction of the detached cells was lysed for Western blotting with an anti-GFP antibody. The rest of the cells were plated on poly-D-lysine-coated glass coverslips and stained for expression of the DN proteins in order to determine co-transfection efficiency. After 4 h incubation at 371C, the cells in the top chamber of the Transwell unit were removed by swabbing with a cotton tip and the cells adhering to the bottom were fixed with 4% paraformaldehyde. The number of GFP-positive cells from two to three independent fields were counted per well and each experiment was performed in triplicates. The average number of GFP cells was multiplied by the co-transfection efficiency and divided by GFP loading levels (NIH Image 1.58) in order to minimize errors resulting from GFP loading and different co-transfection efficiencies. All the migration values were expressed relative to the Pten þ / þ migration value, which is arbitrarily set as 1. A similar protocol was employed for the adenoviral-infected MEFs, with the exception that the mean number of migrated GFP-positive cells was not calibrated by the co-transfection efficiency.
